MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.radonc.2011.06.035

Медицинская библиотека · Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2011

Hearing preservation after low dose linac radiosurgery for acoustic neuroma depends on initial hearing and time.

Roos Daniel E, Potter Andrew E, Zacest Andrew C

СтатьяПеревод пока не подготовлен

Аннотация

PURPOSE: To assess long term outcomes and factors determining hearing preservation after low dose linac stereotactic radiosurgery (SRS) for acoustic neuroma (AN) at the Royal Adelaide Hospital using prospectively collected data.

MATERIAL AND

METHODS

Between 1994 and 2010, 102 patients had SRS for AN. Five patients had neurofibromatosis type 2, six sporadic cases had relapsed after surgery, and the remaining 91 sporadic cases had primary SRS. Dose was 12 or 14 Gy. Sustained changes ≥ 2 mm in any diameter were deemed significant, and useful hearing was defined as inter-aural pure tone average (PTA) ≤ 50 dB. Possible prognostic factors for hearing retention were tested by dividing the patients at pre-specified cutpoints: age (60 years), maximum tumour diameter (20mm), initial PTA (20 dB) and dose (12 vs 14 Gy).

RESULTS

Eighty-four of the 91 sporadic primary SRS cases were evaluable for tumour control with at least one post-treatment MRI. Their median follow-up was 65 mo (range 10-184 mo). Eighty-two (97.6%) were controlled, the remaining two requiring salvage surgery for progression at 5.75 and 9.75 years. Also, one of the post-operative cases required surgery at 2.1 years after SRS. For the 50 sporadic primary SRS patients with initially useful hearing, median age was 56 (range 21-76), median initial PTA 16 dB (range -11 to +45 dB) and median tumour diameter 21 mm (range 10-33 mm). Four received 14 Gy, the rest 12 Gy. After SRS, 19 patients (38%) retained useful hearing. The Kaplan-Meier estimated preservation rate at 5 years was 50% (95% CI 36-64%) but by 10 years, this had fallen to 23% (95% CI 12-41%). On univariate analysis, the only significant factor was initial PTA (P < 0.0001). The estimated risk of hearing loss after SRS for patients with initial PTA ≥ 20 dB was 5.0 (95% CI 2.2-11.2) times that with PTA < 20 dB.

CONCLUSIONS

Tumour control was excellent (99/102=97% freedom from surgical salvage). Hearing preservation was strongly dependent on initial PTA, but there was a steady fall-off in hearing out to at least 10 years.

Для цитирования: Roos Daniel E, Potter Andrew E, Zacest Andrew C. Hearing preservation after low dose linac radiosurgery for acoustic neuroma depends on initial hearing and time.. Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology. 2011. DOI: 10.1016/j.radonc.2011.06.035.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.